The CATS Foundation presented a poster titled “A view into the Tay Sachs variants’ populations using the GM2 Disease Registry” at International Society for Pharmacoepidemiology (ISPE)’s 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 37). The event, held virtually due to the COIVD pandemic enabled us to share insights discovered in the data collected in the GM2 Disease Registry (GM2DR).
About ISPE
The International Society for Pharmacoepidemiology (ISPE) is an international organization dedicated to advancing the health of the public by providing a global forum for the open exchange of scientific information and for the development of policy, education, and advocacy for the field of pharmacoepidemiology, including such areas as pharmacovigilance, drug utilization research, comparative effectiveness review, and therapeutic risk management. ISPE members represent the various scientific disciplines involved in studying drugs. Members are employed by the pharmaceutical industry, academic institutions, government agencies, non-profit and for-profit private organizations.
A view into the Tay Sachs variants’ populations using the GM2 Disease Registry
Highlights
The poster explores the variants of Tay-Sachs in the data collected in the GM2DR.
Key message
There are multiple variants of Tay-Sachs and each displays symptoms at different times.
How to share
The poster can be shared via the button at the top of this page.
Reference the publication
The reference for the poster publication is below.
Lewi, D., Furegato, M., Brignoli, L., & Matos, J. E. (2022). A view into the Tay Sachs variants’ populations using the GM2 Disease Registry. Pharmacoepidemiology and Drug Safety, 31(Supplement 2), 3-628. https://doi.org/10.1002/pds.5518
